Corcept Therapeutics Incorporated (CORT): Price and Financial Metrics
Today's Latest Price: $28.60 USD
Jan 27 3:33pm Add CORT to Watchlist Sign Up
Buy & Hold Grade
Peer Grade Industry Rank
CORT Stock Summary The ratio of debt to operating expenses for Corcept Therapeutics Inc is higher than it is for about merely 5.18% of US stocks. Equity multiplier, or assets relative to shareholders' equity, comes in at 1.1 for Corcept Therapeutics Inc; that's greater than it is for just 9.2% of US stocks. With a year-over-year growth in debt of 293.64%, Corcept Therapeutics Inc's debt growth rate surpasses 94.64% of about US stocks. Stocks with similar financial metrics, market capitalization, and price volatility to Corcept Therapeutics Inc are AMPH, FORM, LSCC, BMRN, and PXLW. Visit CORT's SEC page to see the company's official filings. To visit the company's web site, go to www.corcept.com.
CORT Price/Volume Stats
Corcept Therapeutics Incorporated (CORT) Company Bio
Corcept Therapeutics engages in the discovery, development, and commercialization of drugs for the treatment of metabolic, oncologic, and psychiatric disorders. The company was founded in 1998 and is based in Menlo Park, California.
CORT Latest News Stream
All News Types
Loading, please wait...
Latest CORT News From Around the Web
Below are the latest news stories about Corcept Therapeutics Inc that investors may wish to consider to help them evaluate CORT as an investment opportunity.
Corcept's (CORT) Cushing's syndrome drug Korlym is witnessing higher sales and a strong uptake since its approval. Other pipeline candidates are also advancing well.
Joseph Belanoff became the CEO of Corcept Therapeutics Incorporated ( NASDAQ:CORT ) in 1999, and we think it's a good...
In this article we will analyze whether Corcept Therapeutics Incorporated (NASDAQ:CORT) is a good investment right now by following the lead of some of the best investors in the world and piggybacking their ideas. There’s no better way to get these firms’ immense resources and analytical capabilities working for us than to follow their lead […]
Corcept (CORT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Potential Corcept Therapeutics Incorporated (NASDAQ:CORT) shareholders may wish to note that the Independent Director...
Read More 'CORT' Stories Here
CORT Price Returns
Get Free Updates
Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!
Page generated in 0.9656 seconds.